Westpac Banking Corp lifted its position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 29.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 201,715 shares of the biopharmaceutical company's stock after acquiring